Pharmaceuticals
Batch traceability and QC control for pharma production
Pharmaceutical production is defined by control: every lot inspected, every batch documented, every unit traceable. IEMSuite enforces those gates as part of the workflow.
The challenges in pharmaceuticals
Unapproved stock must never reach production or a shipment.
Every batch needs a complete, tamper-proof production record.
Expiry and quarantine status must be enforced, not remembered.
How IEMSuite helps
Every capability below is a feature that ships today - mapped to what pharmaceuticals operations need most.
Quarantine gates
New lots enter as PENDING_QC and cannot be allocated until an inspection passes - quarantine and rejection are first-class states.
Batch production records
Every batch records the recipe, the exact lots consumed, yield, and QC checkpoints as an immutable history.
Non-conformance workflow
Failed inspections raise an NCR with severity and resolution tracking, holding the lot out of circulation.
Expiry enforcement
Expiry dates drive FEFO allocation and alerts, so time-sensitive stock is used or flagged in order.
How a batch moves through pharmaceuticals
- 1
API and excipient receipt
Each component arrives as a lot carrying its supplier, CoA reference, retest date and the unit cost you actually paid.
- 2
Quarantine and release
Components hold at PENDING_QC. Nothing can be allocated to a batch until inspection passes, so release is a gate rather than a note.
- 3
Batch manufacture
The recipe consumes released lots only. Yield, actual quantities and the operator are recorded against the batch as it happens.
- 4
Finished goods and deviation
A failed in-process check quarantines the batch and opens an NCR with its own trail, so a deviation has a record rather than an email thread.
Standards pharmaceuticals operations work under
IEMSuite is not certified against any of these. What it does is hold the records they ask you to be able to produce.
21 CFR Parts 210 and 211 (cGMP)
- What it asks for
- A complete batch production and control record for every lot, including components used, equipment, in-process checks and the signature releasing it.
- Where the record comes from
- Batch records link components, quantities, QC results and the actor on each step, and stock history cannot be edited after the fact. This is record keeping, not validation: IEMSuite is not a validated system and a regulated manufacturer would need to qualify it themselves before relying on it in a GMP context.
21 CFR Part 11 electronic records
- What it asks for
- Attributable, legible, contemporaneous, original and accurate records, with audit trails showing who changed what and when.
- Where the record comes from
- Every stock movement and user action is logged with timestamp and actor, and history is append-only. Part 11 also requires validated electronic signatures and system qualification, which IEMSuite does not provide today. Treat that gap as real.
DSCSA serialization
- What it asks for
- Product identifiers at the package level and transaction information that follows the unit through the supply chain.
- Where the record comes from
- IEMSuite tracks at lot level, not at unit serial level. For DSCSA unit serialization you would need a dedicated serialization system alongside it. Lot genealogy still covers the manufacturing side of the chain.
Audit-ready by design
Forward/backward genealogy and immutable QC + stock records give you the documentation trail regulated production requires.
Pharmaceuticals inventory questions
What is lot genealogy and why do pharmaceutical auditors ask for it?
Lot genealogy is the linked record of which component lots went into which batch, and which batches went into which shipments. Auditors ask for it because it is the only way to bound the scope of a problem. Without it, a single out-of-specification API lot means recalling everything made in the window rather than the batches that actually contained it.
What does quarantine mean in pharmaceutical inventory management?
Quarantine is stock that physically exists but is not available to use. The distinction only matters if the system enforces it. If quarantined stock can still be allocated to a batch because the status is a label rather than a rule, quarantine is documentation, not control.
Is IEMSuite validated for GMP use?
No. IEMSuite provides the record keeping GMP asks for - batch records, audit trail, enforced QC gating - but it is not a validated system and it does not provide Part 11 electronic signatures. A regulated manufacturer would need to perform their own qualification, and for unit-level serialization under DSCSA would need a separate system.
How should a small pharma manufacturer handle retest dates?
Treat the retest date as a property of the lot and let allocation respect it, the same way an expiry date drives FEFO. The failure mode is a lot that passed its retest date sitting in available stock because the date lived on a certificate in a folder rather than on the record the system allocates from.